SUNNYVALE, Calif., April 9, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its third quarter of fiscal year 2012, ended March 31, 2012 on Tuesday, May 8, 2012 after the market closes.
A conference call to review the results of its third quarter of fiscal year 2012 will begin at 2:00 p.m. PDT/5:00 p.m. EDT and will be hosted by Euan S. Thomson, Ph.D., president and chief executive officer and Derek Bertocci, senior vice president and chief financial officer.
The conference call dial-in numbers are 1-866-203-3206 (USA) or 1-617-213-8848 (International), Conference ID: 41410037. In addition, a dial-up replay of the conference call will be available beginning May 8, 2012 at 5:00 p.m. PDT/8:00 p.m. EDT and ending on May 14, 2012. The replay telephone number is 1-888-286-8010 (USA) or 1-617-801-6888 (International), Conference ID: 59135049.
A live webcast of the call will also be available from the Investor Relations section of the corporate website at http://www.accuray.com/investors. A webcast replay can be accessed on the corporate website beginning Tuesday, May 8, 2012 at approximately 5:00 p.m. PDT/8:00 p.m. EDT. The replay will remain available until Accuray announces its results for the fourth quarter of fiscal 2012, ending June 30, 2012.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company that develops, manufactures and sells personalized innovative treatment solutions that set the standard of care, with the aim of helping patients live longer, better lives. The Company’s leading edge technologies the CyberKnife and TomoTherapy Systems are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. To date, more than 300,000 patients worldwide have been treated using the Company’s technologies and more than 616 systems have been installed in leading hospitals around the world. For more information, please visit www.accuray.com.
SOURCE Accuray Incorporated
